Papers
Research literature with structured metadata.
Trials
Registered studies by status, phase, and compound.
Topics
Indications and themes psychedelics are researched for.
Compounds
Evidence across molecules with rich data.
Countries
Regulation, access, and research activity by region.
Stakeholders
Organizations shaping the space across research, policy, and funding.
People
Investigators, clinicians, and authors with mapped output.
Courses
Training programs and certifications across modalities.
Events
Conferences, workshops, and convenings by date and focus.
Research recaps
Monthly evidence summaries with key takeaways.
Map of research
Landscape view of trials, compounds, and outcomes.
Newsletter
Weekly or daily updates on trials, publications, analysis, and more.
Research Groups
Worldwide map of psychedelic research centres by region.
Research Network
Interactive co-authorship map of psychedelic researchers.
Top papers
Find needles in the haystack of psychedelic research per topic.
This rat study demonstrated a causal link between reduced prefrontal mGluR2 receptor function and both impaired executive control and alcohol craving. It finds that psilocybin restored mGluR2 expression and reduced alcohol relapse behaviour, identifying a potential biomarker strategy for treating alcohol dependence.
Analysing 6,850 free-form testimonials across 27 hallucinogens with 40 neurotransmitter receptor proxies mapped to brain coordinates, the study uses pattern-learning to link distinct subjective experience themes to cortex-wide receptor density distributions. It finds that ego-dissolution relates to a 5-HT2A, D2, KOR and NMDA receptor constellation anchored in higher-order associative and visual cortices, and more broadly identifies association–sensory gradients that map the semantic structure of psychedelic experiences onto brain receptor architecture with potential therapeutic implications.